Peaking of MMP-26 and TIMP-4 marks invasive transition in prostate cancer

Cell Research

Volumn 16, Issue 9, 2006, Pages 741-

  Li, Dangsheng ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE; MMP26 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TISSUE INHIBITOR OF METALLOPROTEINASE-4;

CANCER INVASION; EDITORIAL; ENZYMOLOGY; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

BIOLOGICAL MARKERS; HUMANS; MALE; MATRIX METALLOPROTEINASES, SECRETED; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33748709220     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7310094     Document Type: Editorial

References (3)

1. Zhao YG, Xiao AZ, Newcomer RG, et al. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 2003; 278:15056-15064.
2. Lee S, Desai KK, Iczkowski KA, et al. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res 2006; 16:750-758.
3. Zhao YG, Xiao AZ, Park HI, et al. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 2004; 64:590-598.